(Q47710513)

5 February 2018

title

The combination of cyclophosphamide and human T cells genetically engineered to target CD19 can eradicate established B-cell lymphoma (English)

1 reference

5 February 2018

author name string

Eleanor J Cheadle

series ordinal

1

1 reference

5 February 2018

David E Gilham

series ordinal

2

1 reference

5 February 2018

Robert E Hawkins

series ordinal

3

1 reference

5 February 2018

language of work or name

English

0 references

publication date

8 May 2008

1 reference

5 February 2018

British Journal of Haematology

published in

1 reference

5 February 2018

volume

142

1 reference

5 February 2018

issue

1

1 reference

5 February 2018

page(s)

65-68

1 reference

5 February 2018

Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07145.X

Killing of non-Hodgkin lymphoma cells by autologous CD19 engineered T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07145.X

T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07145.X

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07145.X

Retroviral vectors for high-level transgene expression in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07145.X

Natural history of HLA expression during tumour development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07145.X

Primary polyclonal human T lymphocytes targeted to carcino-embryonic antigens and neural cell adhesion molecule tumor antigens by CD3zeta-based chimeric immune receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07145.X

Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07145.X

Retroviral vector-mediated expression of HoxB4 in hematopoietic cells using a novel coexpression strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07145.X

CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07145.X

Target antigen expression on a professional antigen-presenting cell induces superior proliferative antitumor T-cell responses via chimeric T-cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07145.X

10.1111/J.1365-2141.2008.07145.X

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018